Page 188 - Molecular features of low-grade developmental brain tumours

7
186
CHAPTER 7
70. Belien, A. T., Paganetti, P. A. & Schwab, M. E. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 144, 373-384, doi:10.1083/jcb.144.2.373 (1999).
71. Broekaart, D. W. M. et al. Increased matrix metalloproteinases expression in tuberous sclerosis complex: modulation by microRNA 146a and 147b in vitro. Neuropathol Appl Neurobiol 46, 142-159, doi:10.1111/nan.12572 (2020).
72. Boer, K. et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 78, 7-21, doi:10.1016/j.eplepsyres.2007.10.002 (2008).
73. Prabowo, A. S. et al. Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation. Brain Pathol 23, 45-59, doi:10.1111/j.1750-3639.2012.00616.x (2013).
74. Zhang, B., Zou, J., Rensing, N. R., Yang, M. & Wong, M. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Neurobiol Dis 80, 70-79, doi:10.1016/j. nbd.2015.04.016 (2015).
75. Gidday, J. M. et al. Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289, H558-568, doi:10.1152/ajpheart.01275.2004 (2005).
76. Justicia, C. et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 23, 1430- 1440, doi:10.1097/01.WCB.0000090680.07515.C8 (2003).
77. Ramachandran, R. K., Sorensen, M. D., Aaberg-Jessen, C., Hermansen, S. K. & Kristensen, B. W. Expression and prognostic impact of matrix metalloproteinase-2 (MMP-2) in astrocytomas. PLoS One 12, e0172234, doi:10.1371/journal.pone.0172234 (2017).
78. Wang, L. et al. Co-expression of MMP-14 and MMP-19 predicts poor survival in human glioma. Clin Transl Oncol 15, 139-145, doi:10.1007/s12094-012-0900-5 (2013).
79. Thorns, V., Walter, G. F. & Thorns, C. Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas. Anticancer Res 23, 3937-3944 (2003).
80. Stojic, J. et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60, 40-49, doi:10.1016/j. neures.2007.09.009 (2008).
81. Kachra, Z. et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Clin Exp Metastasis 17, 555-566, doi:10.1023/a:1006760632766 (1999).
82. Lettau, I. et al. Matrix metalloproteinase-19 is highly expressed in astroglial tumors and promotes invasion of glioma cells. J Neuropathol Exp Neurol 69, 215-223, doi:10.1097/NEN.0b013e3181ce9f67 (2010).
83. Vandenbroucke, R. E. & Libert, C. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat Rev Drug Discov 13, 904-927, doi:10.1038/nrd4390 (2014).
84. Xia, H. et al. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 1269, 158-165, doi:10.1016/j.brainres.2009.02.037 (2009).
85. 85 Qin, C. Z. et al. Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma. Chem Biol Drug Des 89, 806-814, doi:10.1111/cbdd.12906 (2017).
86. Ames, H. M., Yuan, M., Vizcaino, M. A., Yu, W. & Rodriguez, F. J. MicroRNA profiling of low-grade glial and glioneuronal tumors shows an independent role for cluster 14q32.31 member miR-487b. Mod Pathol 30, 204-216, doi:10.1038/modpathol.2016.177 (2017).
87. Czarnecka, K. H. et al. A Strong Decrease in TIMP3 Expression Mediated by the Presence of miR-17